Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
Chinese Patent Office
Covington
Julphar
Healthtrust
Chubb
Federal Trade Commission
Daiichi Sankyo
Accenture

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022287

« Back to Dashboard

NDA 022287 describes DEXILANT, which is a drug marketed by Takeda Pharms Usa and is included in two NDAs. It is available from three suppliers. There are twenty-one patents protecting this drug and two Paragraph IV challenges. Additional details are available on the DEXILANT profile page.

The generic ingredient in DEXILANT is dexlansoprazole. There are fifteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the dexlansoprazole profile page.
Summary for 022287
Tradename:DEXILANT
Applicant:Takeda Pharms Usa
Ingredient:dexlansoprazole
Patents:15
Pharmacology for NDA: 022287
Mechanism of ActionProton Pump Inhibitors
Medical Subject Heading (MeSH) Categories for 022287
Suppliers and Packaging for NDA: 022287
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXILANT dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 022287 NDA Physicians Total Care, Inc. 54868-5998 E 54868-5998-1
DEXILANT dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 022287 NDA Physicians Total Care, Inc. 54868-5998 E 54868-5998-0

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED RELEASE;ORALStrength30MG
Approval Date:Jan 30, 2009TE:RLD:Yes
Regulatory Exclusivity Expiration:Jul 8, 2019
Regulatory Exclusivity Use:NEW PATIENT POPULATION
Patent:➤ Try a Free TrialPatent Expiration:Dec 15, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Try a Free TrialPatent Expiration:Jul 30, 2023Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 022287

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Takeda Pharms Usa DEXILANT dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 022287-001 Jan 30, 2009 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa DEXILANT dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 022287-001 Jan 30, 2009 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa DEXILANT dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 022287-002 Jan 30, 2009 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa DEXILANT dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 022287-001 Jan 30, 2009 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa DEXILANT dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 022287-002 Jan 30, 2009 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa DEXILANT dexlansoprazole CAPSULE, DELAYED RELEASE;ORAL 022287-002 Jan 30, 2009 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Express Scripts
UBS
Argus Health
Moodys
Colorcon
Dow
Fuji
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot